N-(2-Chloropyrimidin-4-Yl)-N,2,3-Trimethyl-2h-Indazol-6-Amine CAS:444731-75-3

This compound has significant potential applications in drug discovery and medicinal chemistry. Its structural components suggest that it may interact with various biological targets, making it suitable for the development of therapeutic agents. Particularly, N-(2-Chloropyrimidin-4-Yl)-N,2,3-trimethyl-2H-indazol-6-amine could be explored for its anti-cancer properties, as indazole derivatives have shown promise in targeting specific cancer cell pathways. Additionally, the compound might exhibit anti-inflammatory effects, which can be beneficial in treating conditions characterized by excessive inflammation. Researchers are investigating its role in modulating signaling pathways associated with inflammatory responses, potentially leading to new treatments for chronic diseases. Moreover, this compound can serve as a lead structure for synthesizing novel derivatives with improved efficacy and selectivity. Its versatility extends to research applications in pharmacology and biochemistry, where understanding its mechanisms may shed light on new therapeutic strategies. Overall, this compound holds promise as a valuable tool in advancing pharmaceutical research and development.